Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating the combination of afatinib (BIBW 2992) and cetuximab in non-small cell lung cancer has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer [Phase 4]
This update notes a Phase 4 trial evaluating chemotherapy in combination with Yangzhengxiaoji Capsule for advanced non-small cell lung cance…
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact. [NA]
A clinical trial update evaluating the time course of dMR during first-line treatment of non-small cell lung cancer and its potential progno…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer [Phase 1]
Phase 1 dose-escalation study of BIBF 1120 (nintedanib) in combination with pemetrexed for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer [Phase 1]
Phase 1 dose-escalation study evaluating the combination of BIBF 1120 (nintedanib) with paclitaxel and carboplatin in advanced non-small-cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC [Phase 4]
A Phase 4 clinical trial from Betta Pharmaceuticals compares sequential and maintenance icotinib plus chemotherapy with icotinib maintenance…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer [Phase 1]
This Phase 1 clinical trial update reports on MORAb-009 in pancreatic cancer and mesothelioma, with related ovarian cancer and non-small cel…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer [Phase 2]
Phase 2 study evaluating concurrent intensity-modulated radiotherapy with docetaxel and cisplatin or carboplatin, followed by adjuvant chemo…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2, Phase 3]
The document reports the completion of a Phase 2/Phase 3 clinical trial evaluating TG4010 immunotherapy in patients with advanced non-small …
-
FDA approval · 2014-07-10FDA Approved: DOCETAXEL — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for Docetaxel.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating Tarceva (erlotinib) as monotherapy in patients with advanced non-small cell lung cancer has completed, with results…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer [Phase 2]
This is a Phase 2 trial evaluating bevacizumab in combination with docetaxel and cisplatin for metastatic or locally advanced non-small cell…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients [Phase 2]
A Phase 2 trial evaluated Racotumomab immunotherapy versus supportive care in patients with advanced non-small cell lung cancer; the study h…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. [Phase 2]
Phase 2 study of Tarceva (erlotinib) in combination with platinum-based chemotherapy in non-small cell lung cancer; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial assessing the safety, efficacy, and pharmacokinetics of regorafenib in combination with pemetrexed and cisplatin in nonsquamou…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed disodium, gemcitabine, and bevacizumab in Stage IIIB/IV non-small cell lung cancer; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
This is a Phase 2 trial of dose-dense induction/neoadjuvant chemotherapy for locally advanced non-small cell lung cancer that was terminated…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Phase 2]
Phase 2 study comparing a cisplatin/vinorelbine/bevacizumab regimen followed by docetaxel/gemcitabine/bevacizumab versus cisplatin/docetaxel…
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) [Phase 1]
This document provides an update on a Phase 1 trial evaluating EMD 521873 in combination with radiotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Pfizer withdrew a Phase 3 trial evaluating CP-751,871 in combination with gemcitabine and cisplatin for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Erlotinib and Cetuximab with or without Bevacizumab in patients with metastatic or unresectable k…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages [Phase 2]
Phase 2 trial evaluating photodynamic therapy with HPPH for advanced non-small cell lung cancer causing airway obstruction was terminated, w…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC [Phase 1, Phase 2]
Phase I/II study of nab-paclitaxel and carboplatin with concurrent radiation therapy for unresectable stage III non-small cell lung cancer w…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated adjuvant cisplatin with either genomic-guided vinorelbine or pemetrexed in early-stage non-small cell lung cancer.…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in relapsed or refractory non-small cell lung cancer among non-smokers or former light smokers; trial ter…